Vestal Point Capital, LP Portfolio Holdings
Vestal Point Capital, LP
- $1.4 Trillion
- Q1 2025
Vestal Point Capital, LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $1.4 Trillion distributed in 63 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Arcellx, Inc. with a value of $157B, Cytokinetics Inc with a value of $104B, Insmed Inc with a value of $82B, Nuvalent, Inc. with a value of $76.2B, and Vera Therapeutics, Inc. with a value of $60.1B.
Examining the 13F form we can see an decrease of $286B in the current position value, from $1.69T to 1.4T.
Vestal Point Capital, LP is based out at New York, NY
Below you can find more details about Vestal Point Capital, LP portfolio as well as his latest detailed transactions.